Up-regulation of CD44 variant exon expression in endometrial carcinomas: Analysis of mRNA and protein isoforms, and relation to clinicopathological factors

Japanese Journal of Cancer Research

Volumn 89, Issue 3, 1998, Pages 291-298

  Saegusa, Makoto ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD44; Endometrial carcinoma; RT PCR; Southern blot; Western blot

Indexed keywords

CD44V ANTIGEN; MESSENGER RNA; PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; EXON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOUTHERN BLOTTING; TUMOR GROWTH;

EID: 0031969257     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00561.x     Document Type: Article

References (37)

1. Haynes, B. F., Telen, M. J., Hale, L. P. and Denning, S. M. CD44: a molecule involved in leukocyte adherence and T-cell activation, Immunol. Today, 10, 423-428 (1989).
2. Underhill, C. CD44: the hyaluronan receptor. J. Cell Sci., 103, 293-298 (1992).
3. Gunthert, U. CD44: a multitude of isoforms with diverse functions. Curr. Top. Microbiol. Immunol., 184, 47-63 (1993).
4. Lesley, J., Hyman, R. and Kincade, P. W. CD44 and its interaction with extracellular matrix. Adv. Immunol., 54, 271-335 (1993).
5. Screaton, G. R., Bell, M. V., Bell, J. I. and Jackson, D. G. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J. Biol. Chem., 268, 12235-12238 (1993).
6. Tolg, C., Hofman, M., Herrlich, P. and Ponta, H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res., 21, 1225-1229 (1993).
7. Fox, S. B., Fawcett, J., Jackson, D. G., Collins, I., Gatter, K. C., Harris, A. L., Gearing, A. and Simmons, D. L. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res., 54, 4539-4546 (1994).
8. Mackay, C. R., Terpe, H.-J., Stauder, R., Marston, W. L., Stark, H. and Gunthert, U. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol., 124, 71-82 (1994).
9. Stamenkovic, I., Aruffo, A., Amiot, M. and Seed, B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J., 10, 343-348 (1991).
10. Rudy, W., Hofmann, M., Schwartz-Albeiz, R., Zoller, M., Heider, K. M., Ponta, H. and Herrlich, P. Two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behaviour. Cancer Res., 53, 1262-1268 (1993).
11. Reber, S., Matzku, S., Gunthert, H., Ponta, P., Herrlich, P. and Zoller, M. Retardation of metastatic tumor growth after immunisation with metastasis-specific monoclonal antibodies. Int. J. Cancer, 46, 919-927 (1990).
12. Kaufmann, M., Heider, K. H., Sinn, H. P., von Minckwitz, G., Ponta, H. and Herrlich, P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet. 345, 615-619 (1995).
13. Matsumura, Y., Hanbury, D., Smith, J. and Tarin, D. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. Br. Med. J., 308, 619-624 (1994).
14. Tanabe, K. K., Ellis, L. M. and Saya, H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet, 341, 725-726 (1993).
15. Matsumura, Y., Sugiyama, M., Matsumura, S., Hayle, A. J., Robinson, P., Smith, J. C. and Tarin, D. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J. Pathol., 177, 11-20 (1995).
16. Yoshida, K., Bolodeoku, J., Sugino, T., Goodison, S., Matsumura, Y., Warren, B. F., Toge, T., Tahara, E. and Tarin, D. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res., 55, 4273-4277 (1995).
17. Fujita, N., Yaegashi, N., Ide, Y., Sato, S., Nakamura, M., Ishiwata, I. and Yajima, A. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res., 54, 3922-3928 (1994).
18. Creasman, W. T. Announcement, FIGO stages: 1988 revisions. Gynecol. Ontol., 35, 125-127 (1989).
19. Matsumura, Y. and Tarin, D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-1058 (1992).
20. Gotley, D. C., Fawcett, J., Walsh, M. D., Reeder, J. A., Simmons, D. L. and Antalis, T. M. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br. J. Cancer, 74, 342-351 (1996).
21. Horstmann, M. A., Posl, M., Scholz, R. B., Anderegg, B., Simon. P., Baumgaertl, K., Delling, G. and Kabisch, H. Frequent reduction or loss of DCC gene expression in human osteosarcoma. Br. J. Cancer, 75, 1309-1317 (1997).
22. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685 (1970).
23. Herold-Mende, C., Seiter, S., Born, A., Patzelt, E., Schupp, M., Zoller, J., Bosch F. X. and Zoller, M. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J. Pathol., 179, 66-73 (1996).
24. Seiter, S., Tilgen, W., Herrmann, K., Schadendorf, D., Patzelt., E., Moller, P. and Zoller, M. Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Arch., 428, 141-149 (1996).
25. Sugiyama, M., Woodman, A., Sugino, T., Crowley, S., Ho, K., Smith, J., Matsumura, Y. and Tarin, D. Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine. J. Clin. Pathol. Mol. Pathol., 48, M142-M147 (1995).
26. Behzad, F., Seif, M. W., Campbell, S. and Aplin, J. D. Expression of two isoforms of CD44 in human endometrium. Biol. Reprod., 51, 739-747 (1994).
27. Terpe, H. J., Stark, H., Prehm, P. and Günthert, U. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemisty, 101, 79-89 (1994).
28. Terpe, H.-J., Koopmann, R., Imhof, B. A. and Günthert, U. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms arc preferentially expressed in high-grade malignant lymphomas. J. Pathol., 174, 89-100 (1994).
29. Wielenga, V. J. M., Heider, K.-H., Offerhaus, G. J. A., Adolf, G. R., van den Berg, F. M., Ponta, H., Herrlich, P. and Pals, S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53, 4754-4756 (1993).
30. Washington, M. K., Gottfried, M. R. and Telen, M. J. Expression of the cell adhesion molecule CD44 in gastric adenocarcinoma. Lab. Invest., 68, 52A (1993).
31. Gross, N., Beretta, C., Peruisseau, G., Jackson, D., Simmons, D. and Beck, D. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res., 54, 4238-4242 (1994).
32. Kallakury, B. V. S., Yang, F., Figge, J., Smith, K. E., Kausik, S. J., Tacy, N. J., Fisher, H. A. G., Kaufman, R., Figge, H. and Ross, J. S. Decreased levels of CD44 protein and mRNA in prostate carcinoma: correlation with tumor grade and ploidy. Cancer, 78, 1461-1469 (1996).
33. Sugino, T., Gorham, H., Yoshida, K., Bolodeoku, J., Nargund, V., Cranston, D., Goodison, S. and Tarin, D. Progressive loss of CD44 gene expression in invasive bladder cancer. Am. J. Pathol., 149, 873-882 (1996).
34. Goodison, S., Yoshida, K., Sugino, T., Woodman, A., Gorham, H., Bolodeoku, J., Kaufmann. M. and Tarin, D. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonie tumors. Cancer Res., 57, 3140-3144 (1997).
35. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U. and Bell, J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA, 89, 12160-12164 (1992).
36. Woodman, A. C., Sugiyama, M., Yoshida, K., Sugino, T., Borgya, A., Goodison, S., Matsumura, Y. and Tarin, D. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am. J. Pathol., 149, 1519-1530 (1996).
37. Dall, P., Heider, K.-H., Sinn, H.-P., Skroch-Angel, P., Adolf, G., Kaufmann, M., Herrlich, P. and Ponta, H. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int. J. Cancer, 60, 471-477 (1995)